Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cytokinetics, Incorporated(CYTK) | 0 | 4,575,558 | +4,575,558 | $0 | $246.07M | 28.63% | +$246.07M |
| Insmed Incorporated(INSM) | 0 | 3,541,095 | +3,541,095 | $0 | $237.08M | 27.58% | +$237.08M |
| Vaxcyte, Inc.(PCVX) | 2,750,804 | 2,080,946 | -669,858 | $187.91M | $163.92M | 19.07% | -$23.99M |
| Geron Corporation(GERN) | 0 | 23,915,480 | +23,915,480 | $0 | $106.18M | 12.35% | +$106.18M |
| Keros Therapeutics, Inc.(KROS) | 1,435,950 | 1,525,902 | +89,952 | $95.06M | $68.77M | 8.00% | -$26.29M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 325,140 | +325,140 | $0 | $14.27M | 1.66% | +$14.27M |
| Spyre Therapeutics, Inc.(SYRE) | 473,200 | 452,040 | -21,160 | $17.95M | $10.27M | 1.19% | -$7.68M |
| Avidity Biosciences Inc | 0 | 200,000 | +200,000 | $0 | $8.11M | 0.94% | +$8.11M |
| Elevation Oncology Inc | 2,332,928 | 1,916,290 | -416,638 | $11.97M | $4.81M | 0.56% | -$7.16M |
| Alpine Immune Sciences Inc | 1,982,016 | 0 | -1,982,016 | $78.57M | $0 | — | -$78.57M |
| Apogee Therapeutics Inc | 832,198 | 0 | -832,198 | $55.30M | $0 | — | -$55.30M |
| Beam Therapeutics Inc.(BEAM) | 2,119,598 | 0 | -2,119,598 | $70.03M | $0 | — | -$70.03M |
| Biohaven Ltd.(BHVN) | 1,476,974 | 0 | -1,476,974 | $80.78M | $0 | — | -$80.78M |
| Merck & Co., Inc.(MRK) | 79,600 | 0 | -79,600 | $10.50M | $0 | — | -$10.50M |
| Nuvalent Inc | 1,436,964 | 0 | -1,436,964 | $107.90M | $0 | — | -$107.90M |
| Tourmaline Bio Inc | 465,000 | 0 | -465,000 | $10.65M | $0 | — | -$10.65M |
| Xencor, Inc.(XNCR) | 1,109,650 | 0 | -1,109,650 | $24.56M | $0 | — | -$24.56M |